Michael John Harkins serves as Executive at GenMark Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Michael John Harkins has executed 11 insider transactions totaling $409.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 22, 2021 involved transacting 144,214 shares valued at $3.5M.
Michael John Harkins currently holds 143,611 shares of GenMark Diagnostics, Inc. (GNMK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael John Harkins has been a net seller of GNMK stock. They have purchased $0 and sold $409.5K worth of shares.
Michael John Harkins's most recent insider trade was on Apr 22, 2021, when they sold 144,214 shares at $24.05 per share.
Get notified when new Form 4 filings are submitted
| $17.03 |
| Discretionary |
| Feb 18, 2021 | GNMK | $0 | Award | 11,250 | $N/A | Discretionary |
| Jan 27, 2021 | GNMK | $15.7K | Sale | 1,117 | $14.06 | Discretionary |
| Jan 25, 2021 | GNMK | $104.3K | Sale | 7,338 | $14.22 | Discretionary |
| Jan 21, 2021 | GNMK | $0 | Option Exercise | 19,166 | $N/A | Discretionary |
| Oct 27, 2020 | GNMK | $12.4K | Sale | 1,092 | $11.34 | Discretionary |
| Jul 28, 2020 | GNMK | $18.2K | Sale | 1,052 | $17.30 | Discretionary |
| Apr 29, 2020 | GNMK | $48.0K | Sale | 4,124 | $11.64 | Discretionary |
| Feb 25, 2020 | GNMK | $0 | Award | 43,125 | $N/A | Discretionary |
| Feb 25, 2020 | GNMK | $0 | Award | 43,125 | $N/A | Discretionary |